Silo Pharma, Inc. (NASDAQ:SILO) Sees Large Decline in Short Interest

Silo Pharma, Inc. (NASDAQ:SILO) was the recipient of a large decline in short interest in the month of December. As of December 31st, there was short interest totalling 212,900 shares, a decline of 21.8% from the December 15th total of 272,100 shares. Currently, 5.0% of the company’s shares are sold short. Based on an average daily volume of 2,920,000 shares, the short-interest ratio is currently 0.1 days.

Silo Pharma Trading Down 2.2 %

NASDAQ SILO traded down $0.04 during trading hours on Friday, hitting $1.94. 128,645 shares of the company’s stock were exchanged, compared to its average volume of 16,240,171. Silo Pharma has a 1-year low of $0.77 and a 1-year high of $4.50. The stock has a 50-day simple moving average of $1.08 and a 200 day simple moving average of $1.24.

Silo Pharma Company Profile

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.